SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

71,909.70 -570.59
( -0.79%)

Global Indices

Nasdaq

50,952.25 25.20
(0.05%)

Dow Jones

7,687.74 15.20
(0.20%)

Hang Seng

68,256.51 -700.21
(-1.02%)

Nikkei 225

10,432.22 -173.78
(-1.64%)

Forex

USD-INR

95.92 -0.05
(-0.05%)

EUR-INR

108.79 -0.10
(-0.09%)

GBP-INR

127.19 0.21
(0.17%)

JPY-INR

0.61 0.00
(0.14%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gufic BioSciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

509079

INE742B01025

66.2311355

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GUFICBIO

57.05

4193.81

EPS(TTM)

Face Value()

Div & Yield %

7.33

0.02

Back

acs technologies ltd

GACM Technologies consolidated net profit declines 53.09% in the June 2026 quarter

Aug 13,2026

Net profit of GACM Technologies declined 53.09% to Rs 1.52 crore in the quarter ended June 2026 as against Rs 3.24 crore during the previous quarter ended June 2025. Sales declined 32.84% to Rs 4.50 crore in the quarter ended June 2026 as against Rs 6.70 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	4.50	6.70	-33
OPM %	67.78	57.61	-
PBDT	3.30	4.08	-19
PBT	1.53	3.32	-54
NP	1.52	3.24	-53

71,909.70 -570.59 ( -0.79%)

50,952.25 25.20 (0.05%)

7,687.74 15.20 (0.20%)

68,256.51 -700.21 (-1.02%)

10,432.22 -173.78 (-1.64%)

95.92 -0.05 (-0.05%)

108.79 -0.10 (-0.09%)

127.19 0.21 (0.17%)

0.61 0.00 (0.14%)